188 related articles for article (PubMed ID: 23912487)
21. Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.
Ricon I; Hanalis-Miller T; Haldar R; Jacoby R; Ben-Eliyahu S
Cancer; 2019 Jan; 125(1):45-56. PubMed ID: 30291805
[TBL] [Abstract][Full Text] [Related]
22. Stress-mediated increases in systemic and local epinephrine impair skin wound healing: potential new indication for beta blockers.
Sivamani RK; Pullar CE; Manabat-Hidalgo CG; Rocke DM; Carlsen RC; Greenhalgh DG; Isseroff RR
PLoS Med; 2009 Jan; 6(1):e12. PubMed ID: 19143471
[TBL] [Abstract][Full Text] [Related]
23. Scientists probe link between stress and cancer: Studies show biological responses that appear to affect cancer growth.
Printz C
Cancer; 2018 Jul; 124(13):2671-2672. PubMed ID: 29913050
[No Abstract] [Full Text] [Related]
24. β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β
Dal Monte M; Calvani M; Cammalleri M; Favre C; Filippi L; Bagnoli P
Br J Pharmacol; 2019 Jul; 176(14):2496-2508. PubMed ID: 30471093
[TBL] [Abstract][Full Text] [Related]
25. Psychoneuroimmunology of Cancer - Recent Findings and Perspectives.
Mravec B; Tibenský M; Horváthová Ľ
Klin Onkol; 2018; 31(5):345-352. PubMed ID: 30541320
[TBL] [Abstract][Full Text] [Related]
26. The role of β-blockers in dermatological treatment: a review.
Chen L; Tsai TF
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):363-371. PubMed ID: 28850731
[TBL] [Abstract][Full Text] [Related]
27. Cancer catecholamine conundrum.
Wackerhage H; Christensen JF; Ilmer M; von Luettichau I; Renz BW; Schönfelder M
Trends Cancer; 2022 Feb; 8(2):110-122. PubMed ID: 34776398
[TBL] [Abstract][Full Text] [Related]
28. Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.
Qiao G; Chen M; Bucsek MJ; Repasky EA; Hylander BL
Front Immunol; 2018; 9():164. PubMed ID: 29479349
[TBL] [Abstract][Full Text] [Related]
29. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
30. Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments.
Mravec B; Horvathova L; Hunakova L
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114769
[TBL] [Abstract][Full Text] [Related]
31. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer.
Montoya A; Amaya CN; Belmont A; Diab N; Trevino R; Villanueva G; Rains S; Sanchez LA; Badri N; Otoukesh S; Khammanivong A; Liss D; Baca ST; Aguilera RJ; Dickerson EB; Torabi A; Dwivedi AK; Abbas A; Chambers K; Bryan BA; Nahleh Z
Oncotarget; 2017 Jan; 8(4):6446-6460. PubMed ID: 28031536
[TBL] [Abstract][Full Text] [Related]
32. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
Zhong H; Minneman KP
Mol Pharmacol; 1993 Dec; 44(6):1085-93. PubMed ID: 7903414
[TBL] [Abstract][Full Text] [Related]
33. Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis.
Baerwald CG; Wahle M; Ulrichs T; Jonas D; von Bierbrauer A; von Wichert P; Burmester GR; Krause A
Immunobiology; 1999 Feb; 200(1):77-91. PubMed ID: 10084697
[TBL] [Abstract][Full Text] [Related]
34. Can propranolol prevent progression of melanoma?
Kao J; Luu B
JAAPA; 2019 Jun; 32(6):1-5. PubMed ID: 31136408
[TBL] [Abstract][Full Text] [Related]
35. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival.
Portbury AL; Chandra R; Groelle M; McMillian MK; Elias A; Herlong JR; Rios M; Roffler-Tarlov S; Chikaraishi DM
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2069-77. PubMed ID: 12574001
[TBL] [Abstract][Full Text] [Related]
36. Adrenergic urticaria: a rare underdiagnosed subtype.
Ollaik F; Dagher M; Bachour K; Bachour J
Int J Dermatol; 2020 May; 59(5):615-616. PubMed ID: 31736049
[No Abstract] [Full Text] [Related]
37. Stress, catecholamines, and beta-adrenoceptor blockade.
Greenwood DT
Postgrad Med J; 1990; 66 Suppl 2():S36-40. PubMed ID: 1975439
[No Abstract] [Full Text] [Related]
38. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.
Lemeshow S; Sørensen HT; Phillips G; Yang EV; Antonsen S; Riis AH; Lesinski GB; Jackson R; Glaser R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2273-9. PubMed ID: 21933972
[TBL] [Abstract][Full Text] [Related]
39. β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis.
Childers WK; Hollenbeak CS; Cheriyath P
Clin Breast Cancer; 2015 Dec; 15(6):426-31. PubMed ID: 26516037
[TBL] [Abstract][Full Text] [Related]
40. Adrenergic β2-receptor mediates itch hypersensitivity following heterotypic chronic stress in rats.
Peng XY; Huang Y; Wang XL; Cao LF; Chen LH; Luo WF; Liu T
Neuroreport; 2015 Dec; 26(17):1003-10. PubMed ID: 26426856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
